Intended for healthcare professionals

News

“Illogical” cannabis regulation blocks research into therapeutic uses, say doctors

BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k2780 (Published 25 June 2018) Cite this as: BMJ 2018;361:k2780
  1. Richard Hurley
  1. The BMJ

Doctors should be able to prescribe cannabis legally and research its therapeutic use more easily, 20 prominent UK clinicians and academics have said.

In a letter to The Times on 20 June,1 they “strongly urge the government” to recategorise cannabis from schedule 1 to schedule 2 under the UK Misuse of Drugs Regulations 2001.

Schedule 1 is for illicit substances deemed to have no clinical application and which doctors cannot prescribe; schedule 2 drugs, including, for example, diamorphine (heroin), are subject to requirements relating to prescriptions.

Last week, Savid Javid, the home secretary, said that a panel would be set up to review the evidence for medical cannabis that could see the drug rescheduled.2

Valerie Curran, professor of psychopharmacology at University College London and one of the letter’s …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription